UNSPSC 51334303: Flupentixol

This classification denotes a serotonin antagonist and dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FA0UYH6QUO. European Medicines Agency schedules Flupentixol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07726MIG. Flupentixol generally arises in the molecular formula C23H25F3N2OS. The term FLUPENTIXOL is an International Non-Proprietary Name or INN. FLUPENTIXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule flupentixol under HS 29349990 and SITC 51579. As of Q4 2014, FLUPENTIXOL remains the US FDA Preferred Term for this commodity. Flupentixol bears US NLM identifiers UMLS ID C0016367 and NCI Concept Code C73315. SMILES: S1C2C(/C(=C/CCN3CCN(CC3)CCO)C3C1CCCC3)CC(CC2)C(F)(F)F.

UNSPSC 51334303 Flupentixol is a Commodity code that does not align with the recent state and local procurement activity posted under it. The solicitation records show no purchases of flupentixol, an antipsychotic pharmaceutical. Instead, Seminole County, Florida tagged its procurement under this code while actually soliciting naloxone and safe drug deactivation systems — opioid antagonists and harm-reduction equipment unrelated to flupentixol's therapeutic class. This mismatch indicates either a classification error at the issuing body or a misalignment between the code's nominal scope and current demand signals in state and local purchasing.

The single recent opportunity on record is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems through competitive bidding. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option, and vendors must meet E-Verify, drug-free workplace, and insurance requirements. No explicit set-aside designations are specified. The code shows little relevant recent activity for flupentixol itself; firms pursuing pharmaceutical procurement should verify UNSPSC classification at the issuing body before allocating business development resources to this code.